The epidemiology of Parkinson's disease: risk factors and prevention

被引:1190
|
作者
Ascherio, Alberto [1 ,2 ,3 ]
Schwarzschild, Michael A. [4 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol & Nutr, Boston, MA USA
[2] Brigham & Womens Hosp, Channing Lab, Dept Med, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
来源
LANCET NEUROLOGY | 2016年 / 15卷 / 12期
基金
美国国家卫生研究院;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URIC-ACID LEVELS; CALCIUM-CHANNEL BLOCKERS; BODY-MASS INDEX; LIPID-LOWERING DRUGS; PHYSICAL-ACTIVITY; PLASMA URATE; COFFEE CONSUMPTION; CAFFEINE INTAKE; STATIN USE;
D O I
10.1016/S1474-4422(16)30230-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumption of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been reported in association with smoking, caffeine consumption, higher serum urate concentrations, physical activity, and use of ibuprofen and other common medications. Randomised trials are investigating the possibility that some of the negative risk factors might be neuroprotective and thus beneficial in individuals with early Parkinson's disease, particularly with respect to smoking (nicotine), caffeine, and urate. In the future, it might be possible to identify Parkinson's disease in its prodromal phase and to promote neuroprotective interventions before the onset of motor symptoms. At this time, however, the only intervention that seems justifiable for the primary prevention of Parkinson's disease is the promotion of physical activity, which is likely to be beneficial for the prevention of several chronic diseases.
引用
收藏
页码:1255 / 1270
页数:16
相关论文
共 50 条
  • [1] Epidemiology and prevention of Parkinson's disease
    Elbaz, Alexis
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [2] Epidemiology, environmental risk factors and genetics of Parkinson's disease
    Delamarre, Anna
    Meissner, Wassilios G.
    [J]. PRESSE MEDICALE, 2017, 46 (02): : 175 - 181
  • [3] The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention
    Zhang, X. -X.
    Tian, Y.
    Wang, Z. -T.
    Ma, Y. -H.
    Tan, Lan
    Yu, Jin-Tai
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2021, 8 (03): : 313 - 321
  • [4] The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
    X.-X. Zhang
    Y. Tian
    Z.-T. Wang
    Y.-H. Ma
    Lan Tan
    Jin-Tai Yu
    [J]. The Journal of Prevention of Alzheimer's Disease, 2021, 8 : 313 - 321
  • [5] Prevention of Parkinson's Disease: From Risk Factors to Early Interventions
    Ng, Ming Guan
    Chan, Brendan Jun Lam
    Koh, Rhun Yian
    Ng, Khuen Yen
    Chye, Soi Moi
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (06) : 746 - 760
  • [6] Parkinson's disease risk factors
    Allam, MF
    del Castillo, AS
    Navajas, RFC
    [J]. REVISTA DE NEUROLOGIA, 2003, 36 (08) : 749 - 755
  • [7] Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
    Gonzalez-Latapi, Paulina
    Bayram, Ece
    Litvan, Irene
    Marras, Connie
    [J]. BEHAVIORAL SCIENCES, 2021, 11 (05)
  • [8] Epidemiology, risk factors, and prevention
    Smith, Radhika K.
    Maron, David J.
    [J]. SEMINARS IN COLON AND RECTAL SURGERY, 2016, 27 (04) : 176 - 180
  • [9] Cardiovascular risk factors and the risk of Parkinson's disease
    Vikdahl, M.
    Backman, L.
    Johansson, I.
    Forsgren, L.
    Haglin, L.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2015, 69 (06) : 729 - 733
  • [10] Cardiovascular risk factors and the risk of Parkinson’s disease
    M Vikdahl
    L Bäckman
    I Johansson
    L Forsgren
    L Håglin
    [J]. European Journal of Clinical Nutrition, 2015, 69 : 729 - 733